{
  "docId": "019de517-ef27-7380-abf1-7804147a21c1",
  "docSlug": "35bb8af5e32b82874d7685e3939f2cc9",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 39,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "revenue_buildup",
  "function": "quantify_opportunity",
  "density": "overcrowded",
  "nDataPoints": 16,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de517-ef27-7380-abf1-7804147a21c1/10",
  "deckHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1",
  "deckJsonHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1.json",
  "deckAnchorHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.34,
        "w": 0.25,
        "x": 0.048,
        "y": 0.18
      },
      "kind": "chart",
      "text": "BAUSCH+LOMB $3,768M FY22 $4,146M FY23",
      "attrs": {},
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac61a819-819c-4852-86c6-4be41891ae9a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.37,
        "w": 0.205,
        "x": 0.339,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Vision Care2 65% $2,543M 35% Consumer Contact Lens",
      "attrs": {},
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24cc6e24-02d3-4773-afb8-05bd874e4910",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.37,
        "w": 0.205,
        "x": 0.558,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Surgical 51% $767M 25% 24% Implantables Equipment Consumables/Other",
      "attrs": {},
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32984cb5-e2dc-4947-8d3d-a5170b307323",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.37,
        "w": 0.205,
        "x": 0.777,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Pharmaceuticals2 64% $836M 36% U.S. International",
      "attrs": {},
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47ed5bf4-2a48-4a02-b1ab-93a057da3be8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.012,
        "w": 0.099,
        "x": 0.048,
        "y": 0.946
      },
      "kind": "legend",
      "text": "BAUSCH+LOMB",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f09ebeb-507e-4bb2-b313-d7db220505ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.05,
        "x": 0.365,
        "y": 0.67
      },
      "kind": "metric",
      "text": "+10%",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07576b5b-68c0-40c5-90ea-19e4b5590728",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.05,
        "x": 0.06,
        "y": 0.67
      },
      "kind": "metric",
      "text": "+12%",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46e85ecb-30f7-4ddf-855c-bb3039f98914",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.05,
        "x": 0.06,
        "y": 0.599
      },
      "kind": "metric",
      "text": "+10%",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f605da0-e816-43b3-bb07-526f90559df3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.059,
        "x": 0.803,
        "y": 0.67
      },
      "kind": "metric",
      "text": "+24%",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91cf432b-d24a-4ede-8ce4-82cd4675d429",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.04,
        "x": 0.584,
        "y": 0.67
      },
      "kind": "metric",
      "text": "+7%",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf06a1e0-be31-4c63-aafa-6e824faf10a4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.236,
        "x": 0.544,
        "y": 0.759
      },
      "kind": "paragraph",
      "text": "Continuing demand in Consumables and Equipment, impacted by supply Expanding Premium IOL portfolio, offset by EyeCee One IOL recall",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53ede20f-6d98-4815-a998-412dc76f931d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.236,
        "x": 0.325,
        "y": 0.759
      },
      "kind": "paragraph",
      "text": "Growth in key franchises Lumify®, Eye Vitamins, Dry Eye, Daily SiHy Lens portfolio (+3%, +5% cc¹), excluding Lynchburg disruptions (+7%, +10% cc¹)",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7262cc9e-5e39-4248-970e-914da41b44e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.236,
        "x": 0.763,
        "y": 0.759
      },
      "kind": "paragraph",
      "text": "Leadership in dry eye disease with launch of Miebo® and addition of Xiidra® Strong growth in Vyzulta, U.S. Generics and International Pharma",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "767cd649-072b-494b-b2b9-ad162aa467c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.236,
        "x": 0.058,
        "y": 0.759
      },
      "kind": "paragraph",
      "text": "Strong revenue growth across all segments and key product franchises Approx. -$68M revenue FX headwinds",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77d67fb0-12e3-43d0-9c9a-ed7064bb3c81",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.016,
        "w": 0.459,
        "x": 0.42,
        "y": 0.61
      },
      "kind": "paragraph",
      "text": "FY23 CONSTANT CURRENCY REVENUE GROWTH 1",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a8a7ddd-aece-43d0-bbd1-aeea60d91357",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.159,
        "x": 0.125,
        "y": 0.67
      },
      "kind": "paragraph",
      "text": "FY23 Revenue Growth Constant Currency¹",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c5addeb-2083-4309-84f4-65faee56f1d1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.159,
        "x": 0.125,
        "y": 0.599
      },
      "kind": "paragraph",
      "text": "FY23 Revenue Growth Reported",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7152653-5c1e-4fd7-b419-8f77eb9f9297",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.049,
        "w": 0.724,
        "x": 0.156,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. Constant currency. This is a non-GAAP measure or ratio. See Slide 1 and Appendix for further information on non-GAAP measures and ratios. 2. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the reported results of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar products. The net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2137e57d-06f4-44be-bed4-d4487478319b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.401,
        "x": 0.048,
        "y": 0.06
      },
      "kind": "title",
      "text": "FY23 Revenue Drivers",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6af5c5bf-7462-45d1-8837-9373e63be88a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 8,
      "beatId": "d6fbc6e1-824b-4798-aac9-27095aa32da2",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Desire",
      "beatSlug": "aida-desire",
      "evidence": "The financial results and segment performance create a desire to learn more",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 9,
      "name": "Zoom In",
      "slug": "06-zoom-in",
      "bestFor": "Technical deep-dives, case studies, detailed analysis",
      "matchId": "11fd2762-3225-4b01-8777-53698056e053",
      "evidence": "The document zooms in on revenue drivers and financial performance",
      "position": 0,
      "objective": "What drives revenue growth?",
      "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication",
      "confidence": 0.7,
      "description": "Start broad, then progressively focus on specific details that prove your point"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}